These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 52844)
21. Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha). Dirnhofer S; Freund M; Rogatsch H; Krabichler S; Berger P Hum Pathol; 2000 Aug; 31(8):966-72. PubMed ID: 10987258 [TBL] [Abstract][Full Text] [Related]
22. Human chorionic gonadotropin as a tumor marker. Vaitukaitis JL Ann Clin Lab Sci; 1974; 4(4):276-80. PubMed ID: 4376658 [TBL] [Abstract][Full Text] [Related]
23. Preneoplasia and neoplasia of the bronchus, esophagus, and colon: the use of markers in determining phenotypes and classification. Trump BF; McDowell EM; Shamsuddin AK; Phelps PC; Purnell DM; Wilson TS; Banks-Schlegel SP; Kurland CL; Harris CC Monogr Pathol; 1985; (26):101-39. PubMed ID: 2414648 [No Abstract] [Full Text] [Related]
24. [Tumor markers--possibilities and limitations]. Rose H; Saul G; Wolf G; Moldenhauer H; Kehrberg G Radiobiol Radiother (Berl); 1984; 25(1):7-19. PubMed ID: 6203136 [No Abstract] [Full Text] [Related]
25. [Tumor markers in oncological gynecology]. Vishnevskiĭ AS Vopr Onkol; 1984; 30(8):23-34. PubMed ID: 6207663 [No Abstract] [Full Text] [Related]
26. [Significance of tumor markers in clinical oncology]. Gericke D; Drahovsky D Med Klin; 1979 May; 74(19):701-9. PubMed ID: 88005 [No Abstract] [Full Text] [Related]
30. Clinical utility of oncofetal proteins and hormones as tumor markers. Garrett PE; Kurtz SR Med Clin North Am; 1986 Nov; 70(6):1295-306. PubMed ID: 2431237 [TBL] [Abstract][Full Text] [Related]
32. Presence in normal human testes of a chorionic-gonadotropin-like substance distinct from human luteinizing hormone. Braunstein GD; Rasor J; Wade ME N Engl J Med; 1975 Dec; 293(26):1339-43. PubMed ID: 171576 [TBL] [Abstract][Full Text] [Related]
33. The immune system in gynecologic malignancies. Barber HR; Dorsett B Prog Clin Biol Res; 1981; 70():357-69. PubMed ID: 6171833 [No Abstract] [Full Text] [Related]
34. [Diagnostic criteria for the tumor markers of the body fluids]. Konishi K; Nakagawa S; Watanabe K; Takamura S Rinsho Byori; 1983 Sep; 31(9):945-54. PubMed ID: 6198536 [No Abstract] [Full Text] [Related]
35. Tumour antigens associated with primary mediastinal choriocarcinoma. Forest JC; Talbot J; Pagé M; Loiselle JM Can Med Assoc J; 1977 Dec; 117(12):1386-8. PubMed ID: 73406 [TBL] [Abstract][Full Text] [Related]
36. Ectopic (inappropriate) hormone production by tumors: mechanisms involved and the biological and clinical implications. Baylin SB; Mendelsohn G Endocr Rev; 1980; 1(1):45-77. PubMed ID: 6164550 [No Abstract] [Full Text] [Related]
37. Serial determination of marker substances in ovarian cancer. Stanhope CR; Smith JP; Britton JC; Crosley PK Gynecol Oncol; 1979 Dec; 8(3):284-7. PubMed ID: 92437 [No Abstract] [Full Text] [Related]
38. Alpha subunit of the glycoprotein hormones: secretion by human malignancies. Kourides IA; Schorr-Toshav NL Clin Bull; 1981; 11(3):106-9. PubMed ID: 6279334 [No Abstract] [Full Text] [Related]
39. Assay of protein hormones related to human reproduction: problems of specificity of assay methods and reference standards. Report of a meeting. Acta Endocrinol (Copenh); 1972 Dec; 71(4):625-37. PubMed ID: 4678202 [No Abstract] [Full Text] [Related]
40. [Methodological bases for an approach to the use of screening tests in the biochemical diagnosis of malignant neoplasms]. Bassalyk LS Lab Delo; 1980; (12):727-30. PubMed ID: 6163888 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]